Population
Human abdominal subcutaneous fat (n=12)
Comparison
Insulin, rosiglitazone, and insulin in… vs Control
Design
Preclinical
Authors
Loading...
May link hyperinsulinemia to elevated FFAs in diabetes models; hypothesis-generating and requires human validation.
Chronic treatment of human adipocytes with insulin stimulates lipolysis and LPL protein expression, while the addition of rosiglitazone reduces the lipolytic rate and TNF-alpha secretion, potentially explaining hyperinsulinemia's coexistence with increased free fatty acids in obesity and type 2 diabetes.
McTernan et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: